An Anti-Viral Ayurvedic formulation for the treatment of COVID-19 Patients
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/03/031815
- Lead Sponsor
- Avance Phytotherapies Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Freshly detected and confirmed positive (by means of RT-PCR) COVID-19 patients requiring admission.
Patients on whom no other (specifically targeted to treat COVID-19) treatment has been initiated. (Patients on supportive care can be considered for inclusion).
Patients who have consented (written informed consent) to be treated
with the trial drug as the primary treatment.
Patient is in the age group between 18-65years.
Patient has persistent fever >=99.50 F and is currently maintained on
antipyretics.
Patient is unable to take a deep breath and/ or not able to hold for >= 20
seconds.
Patient has a history of cough since >= 3 days.
Patient has a history of body aches or tiredness or unusual fatigue lately
(>= 7 days).
Patients ability in the investigators opinion to comply with the protocol
procedures.
•Suspected patients with COVID19, but not confirmed by RT-PCR test.
•Confirmed positive Patient on whom already alternative medical treatment has been initiated.
•History of tuberculosis.
•History / evidence of allergy or hypersensitivity to Hydroxychloroquine sulfate or of herbal drugs or to any of the inactive ingredients of the formulation or to any other drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method